Regenicin Inc
OTC:RGIN
Balance Sheet
Balance Sheet Decomposition
Regenicin Inc
Regenicin Inc
Balance Sheet
Regenicin Inc
| Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
3
+2 790%
|
1
-49%
|
0
-76%
|
0
-76%
|
0
-36%
|
0
-91%
|
0
-23%
|
0
+12%
|
0
+237%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
1
|
2
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
5
|
|
| Short-Term Debt |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
4
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
4
+4%
|
2
-56%
|
2
-5%
|
3
+38%
|
3
+21%
|
4
+22%
|
4
+15%
|
5
+16%
|
6
+13%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
11
|
11
|
12
|
13
|
13
|
14
|
15
|
15
|
16
|
|
| Additional Paid In Capital |
9
|
9
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
2
+63%
|
0
+71%
|
1
-229%
|
2
-66%
|
3
-23%
|
4
-24%
|
4
-15%
|
5
-16%
|
6
-13%
|
|
| Total Liabilities & Equity |
0
N/A
|
3
+2 790%
|
1
-49%
|
0
-76%
|
0
-76%
|
0
-36%
|
0
-91%
|
0
-23%
|
0
+12%
|
0
+237%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
116
|
135
|
153
|
153
|
153
|
153
|
153
|
153
|
153
|
153
|
|
| Preferred Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|